David A. Luckenbaugh mainly focuses on Bipolar disorder, Antidepressant, Psychiatry, Internal medicine and Anesthesia. His Antidepressant research integrates issues from Major depressive disorder, Antagonist and Hippocampal formation. David A. Luckenbaugh combines subjects such as Prospective cohort study, Clinical psychology and Risk factor with his study of Psychiatry.
His Internal medicine research incorporates elements of Gastroenterology, Endocrinology, Mood disorders and Brain mapping. The various areas that David A. Luckenbaugh examines in his Anesthesia study include NMDA receptor, Randomized controlled trial and Riluzole. His work investigates the relationship between Ketamine hydrochloride and topics such as Esketamine that intersect with problems in Crossover study.
His primary areas of investigation include Bipolar disorder, Psychiatry, Internal medicine, Major depressive disorder and Depression. His work is dedicated to discovering how Bipolar disorder, Mood are connected with Bipolar I disorder and other disciplines. In general Psychiatry, his work in Anxiety is often linked to Suicidal ideation linking many areas of study.
His Internal medicine research includes themes of Crossover study, Endocrinology, Neuroscience and Gastroenterology. His Major depressive disorder research includes elements of Anhedonia, Working memory, Ketamine, Clinical psychology and Antidepressant. His biological study spans a wide range of topics, including Anesthesia and Pharmacology.
David A. Luckenbaugh mainly investigates Major depressive disorder, Ketamine, Psychiatry, Bipolar disorder and Anesthesia. His Major depressive disorder study is concerned with the larger field of Depression. The study incorporates disciplines such as NMDA receptor, Anterior cingulate cortex, Major depressive episode and Antidepressant, Antidepressant efficacy in addition to Ketamine.
His Anxiety and Mood study in the realm of Psychiatry connects with subjects such as Suicidal ideation. His Bipolar disorder research is multidisciplinary, incorporating perspectives in Early onset, Lithium, Crossover study and Clinical psychology. His studies examine the connections between Anesthesia and genetics, as well as such issues in Riluzole, with regards to Electroconvulsive therapy, GRIN1 and GRIN2B.
The scientist’s investigation covers issues in Major depressive disorder, Ketamine, Antidepressant, Psychiatry and Internal medicine. His studies deal with areas such as Anterior cingulate cortex and Brain mapping as well as Ketamine. His Antidepressant study integrates concerns from other disciplines, such as Anesthesia, NMDA receptor, Dissociative, Pharmacology and Receptor antagonist.
His Anesthesia study combines topics from a wide range of disciplines, such as Lanicemine, Randomized controlled trial and Psychotomimetic. His study on Depression, Anxiety and Bipolar disorder is often connected to Suicidal ideation as part of broader study in Psychiatry. As a part of the same scientific family, David A. Luckenbaugh mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Infralimbic cortex and Mood.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
Carlos A. Zarate;Jaskaran B. Singh;Paul J. Carlson;Nancy E. Brutsche.
Archives of General Psychiatry (2006)
A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados;Lobna Ibrahim;Nancy E. Brutsche;Andrew Newberg.
Archives of General Psychiatry (2010)
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
Carlos A. Zarate;Nancy E. Brutsche;Lobna Ibrahim;Jose Franco-Chaves.
Biological Psychiatry (2012)
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.
Mark A. Frye;Terence A. Ketter;Timothy A. Kimbrell;Timothy A. Kimbrell;Robert T. Dunn.
Journal of Clinical Psychopharmacology (2000)
Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment.
Meena Vythilingam;Eric Vermetten;George M Anderson;David Luckenbaugh.
Biological Psychiatry (2004)
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
Nancy DiazGranados;Lobna A. Ibrahim;Nancy E. Brutsche;Rezvan Ameli.
The Journal of Clinical Psychiatry (2010)
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method
RM Post;KD Denicoff;GS Leverich;LL Altshuler.
The Journal of Clinical Psychiatry (2003)
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.
Gabriele S. Leverich;Lori L. Altshuler;Mark A. Frye;Trisha Suppes.
The Journal of Clinical Psychiatry (2003)
Reduced Serotonin Type 1A Receptor Binding in Panic Disorder
Alexander Neumeister;Earle Bain;Allison C Nugent;Richard E Carson.
The Journal of Neuroscience (2004)
Evidence for continuing neuropsychological impairments in depression
Petra Weiland-Fiedler;Kristine Erickson;Tracy Waldeck;David A. Luckenbaugh.
Journal of Affective Disorders (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: